Yue-Teh Jang is currently the President and CEO of Medeon Biodesign, a Taiwan based medical device product development and investment group.

Dr. Jang spent the last 13 years as general partner of The Vertical Group and has more than 30 years of experience in various executive positions in the health care industry. He was President and Chief Executive Officer of Embol-X, Ensure Medical, Integrated Vascular System, and Kyphon. Prior to that time, Dr. Jang was vice-president for corporate R&D at Boston Scientific, vice-president for R&D at Cardiovascular Imaging Systems, a project manager with Mallinckrodt Medical, and a scientist with Deseret Medical. He currently serves on the Boards of Directors of Inphenix,Medeon Biodesign, Tricorntech, iXensor and Somnics.

Dr. Jang received a B.S. in Materials Science from National Tsing-Hua University, Taiwan and a Ph.D. in Materials Science from the University of Utah.